Net Cash Provided by (Used in) Operating Activities in USD of PLUS THERAPEUTICS, INC. from 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
PLUS THERAPEUTICS, INC. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and change rate from 2010 to Q1 2025.
  • PLUS THERAPEUTICS, INC. Net Cash Provided by (Used in) Operating Activities for the quarter ending 31 Mar 2025 was -$6.17M, a 36.8% decline year-over-year.
  • PLUS THERAPEUTICS, INC. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$10.6M, a 17.9% increase from 2023.
  • PLUS THERAPEUTICS, INC. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$12.9M, a 0.93% increase from 2022.
  • PLUS THERAPEUTICS, INC. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$13M, a 26.2% decline from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Change (%)

PLUS THERAPEUTICS, INC. Quarterly Net Cash Provided by (Used in) Operating Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 -$6.17M -$1.66M -36.8% 01 Jan 2025 31 Mar 2025 10-Q 30 May 2025
Q1 2024 -$4.51M +$1.28M +22.1% 01 Jan 2024 31 Mar 2024 10-Q 30 May 2025
Q1 2023 -$5.79M -$1.92M -49.5% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024
Q1 2022 -$3.88M -$870K -28.9% 01 Jan 2022 31 Mar 2022 10-Q 20 Apr 2023
Q1 2021 -$3.01M -$1.5M -100% 01 Jan 2021 31 Mar 2021 10-Q 21 Apr 2022
Q1 2020 -$1.5M +$1.77M +54.1% 01 Jan 2020 31 Mar 2020 10-Q 22 Apr 2021
Q1 2019 -$3.27M +$849K +20.6% 01 Jan 2019 31 Mar 2019 10-Q 14 May 2020
Q1 2018 -$4.12M 01 Jan 2018 31 Mar 2018 8-K 10 Sep 2019
Q1 2014 -$8.96M +$332K +3.57% 01 Jan 2014 31 Mar 2014 10-Q 12 May 2014
Q1 2013 -$9.29M -$1.58M -20.5% 01 Jan 2013 31 Mar 2013 10-Q 12 May 2014
Q1 2012 -$7.71M +$2.85M +27% 01 Jan 2012 31 Mar 2012 10-Q 10 May 2013
Q1 2011 -$10.6M 01 Jan 2011 31 Mar 2011 10-Q 10 May 2012

PLUS THERAPEUTICS, INC. Annual Net Cash Provided by (Used in) Operating Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$10.6M +$2.3M +17.9% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025
2023 -$12.9M +$121K +0.93% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025
2022 -$13M -$2.69M -26.2% 01 Jan 2022 31 Dec 2022 10-K 05 Mar 2024
2021 -$10.3M -$1.85M -21.9% 01 Jan 2021 31 Dec 2021 10-K 23 Feb 2023
2020 -$8.43M -$2.53M -42.8% 01 Jan 2020 31 Dec 2020 10-K 24 Feb 2022
2019 -$5.91M +$6.07M +50.7% 01 Jan 2019 31 Dec 2019 10-K 22 Feb 2021
2018 -$12M +$6.15M +33.9% 01 Jan 2018 31 Dec 2018 10-K 30 Mar 2020
2017 -$18.1M 01 Jan 2017 31 Dec 2017 8-K 10 Sep 2019
2013 -$34.6M -$2.37M -7.36% 01 Jan 2013 31 Dec 2013 10-K 14 Mar 2014
2012 -$32.2M +$3.13M +8.86% 01 Jan 2012 31 Dec 2012 10-K 14 Mar 2014
2011 -$35.3M -$11.7M -49.8% 01 Jan 2011 31 Dec 2011 10-K 14 Mar 2014
2010 -$23.6M 01 Jan 2010 31 Dec 2010 10-K 15 Mar 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.